King's College London

Research portal

Ethics of regulating competition for women with hyperandrogenism

Research output: Contribution to journalArticlepeer-review

Standard

Ethics of regulating competition for women with hyperandrogenism. / Camporesi, Silvia.

In: Clinics in Sports Medicine, 01.01.2016, p. 293-301.

Research output: Contribution to journalArticlepeer-review

Harvard

Camporesi, S 2016, 'Ethics of regulating competition for women with hyperandrogenism', Clinics in Sports Medicine, pp. 293-301. https://doi.org/10.1016/j.csm.2015.10.003

APA

Camporesi, S. (2016). Ethics of regulating competition for women with hyperandrogenism. Clinics in Sports Medicine, 293-301. https://doi.org/10.1016/j.csm.2015.10.003

Vancouver

Camporesi S. Ethics of regulating competition for women with hyperandrogenism. Clinics in Sports Medicine. 2016 Jan 1;293-301. https://doi.org/10.1016/j.csm.2015.10.003

Author

Camporesi, Silvia. / Ethics of regulating competition for women with hyperandrogenism. In: Clinics in Sports Medicine. 2016 ; pp. 293-301.

Bibtex Download

@article{cd693ab563f04cfcb3b25fe6feb93a7e,
title = "Ethics of regulating competition for women with hyperandrogenism",
abstract = "KEY POINTS1. IAAF Hyperandrogenism Regulations are flawed on a scientific level because it has not been proved that testosterone confers an advantage in competition.2. IAAF Hyperandrogenism Regulations raise issues of consistencies on two levels: other molecular and genetic variations that confer an advantage in competition are not considered unfair; and there is no upper limit for testosterone in the male category.3. IAAF Hyperandrogenism Regulations raise ethical issues at the level of implementation because the trigger for testing is visual perception and hence they pressure female athletes into conforming to stereotypical feminine standards.4. IAAF Hyperandrogenism Regulations raise medical concerns because they unnecessarily medicalize a condition (hyperandrogenism) in female athletes with long-term side effects. 5. We need to be critical of the grounds on which the Court of Arbitration for Sport (CAS) has suspended the IAAF Hyperandrogenism Regulations on July 27, 2015, because CAS is buying into the IAAF flawed assumption that if there were a sufficient body of evidence to demonstrate a correlation between testosterone and competitive advantage, this would be unfair and would constitute grounds to reinstate the hyperandrogenism regulations.",
keywords = "Ethics, hyperandrogenism, Dutee Chand, Caster Semenya, sport, sport medicine",
author = "Silvia Camporesi",
year = "2016",
month = jan,
day = "1",
doi = "10.1016/j.csm.2015.10.003",
language = "English",
pages = "293--301",
journal = "Clinics in Sports Medicine",
issn = "0278-5919",
publisher = "W.B. Saunders Ltd",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Ethics of regulating competition for women with hyperandrogenism

AU - Camporesi, Silvia

PY - 2016/1/1

Y1 - 2016/1/1

N2 - KEY POINTS1. IAAF Hyperandrogenism Regulations are flawed on a scientific level because it has not been proved that testosterone confers an advantage in competition.2. IAAF Hyperandrogenism Regulations raise issues of consistencies on two levels: other molecular and genetic variations that confer an advantage in competition are not considered unfair; and there is no upper limit for testosterone in the male category.3. IAAF Hyperandrogenism Regulations raise ethical issues at the level of implementation because the trigger for testing is visual perception and hence they pressure female athletes into conforming to stereotypical feminine standards.4. IAAF Hyperandrogenism Regulations raise medical concerns because they unnecessarily medicalize a condition (hyperandrogenism) in female athletes with long-term side effects. 5. We need to be critical of the grounds on which the Court of Arbitration for Sport (CAS) has suspended the IAAF Hyperandrogenism Regulations on July 27, 2015, because CAS is buying into the IAAF flawed assumption that if there were a sufficient body of evidence to demonstrate a correlation between testosterone and competitive advantage, this would be unfair and would constitute grounds to reinstate the hyperandrogenism regulations.

AB - KEY POINTS1. IAAF Hyperandrogenism Regulations are flawed on a scientific level because it has not been proved that testosterone confers an advantage in competition.2. IAAF Hyperandrogenism Regulations raise issues of consistencies on two levels: other molecular and genetic variations that confer an advantage in competition are not considered unfair; and there is no upper limit for testosterone in the male category.3. IAAF Hyperandrogenism Regulations raise ethical issues at the level of implementation because the trigger for testing is visual perception and hence they pressure female athletes into conforming to stereotypical feminine standards.4. IAAF Hyperandrogenism Regulations raise medical concerns because they unnecessarily medicalize a condition (hyperandrogenism) in female athletes with long-term side effects. 5. We need to be critical of the grounds on which the Court of Arbitration for Sport (CAS) has suspended the IAAF Hyperandrogenism Regulations on July 27, 2015, because CAS is buying into the IAAF flawed assumption that if there were a sufficient body of evidence to demonstrate a correlation between testosterone and competitive advantage, this would be unfair and would constitute grounds to reinstate the hyperandrogenism regulations.

KW - Ethics

KW - hyperandrogenism

KW - Dutee Chand

KW - Caster Semenya

KW - sport

KW - sport medicine

U2 - 10.1016/j.csm.2015.10.003

DO - 10.1016/j.csm.2015.10.003

M3 - Article

SP - 293

EP - 301

JO - Clinics in Sports Medicine

JF - Clinics in Sports Medicine

SN - 0278-5919

ER -

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454